About Silicon Biosystems
Silicon Biosystems is a company based in Bologna (Italy) founded in 1999 was acquired by Menarini in September 2013. Silicon Biosystems has raised $25.53 million across 3 funding rounds from investors including Innogest Capital and Menarini Group. Silicon Biosystems has completed 1 acquisition, including CellSearch. Silicon Biosystems offers products and services including CELLSEARCH, CellMag, and DEPArray. Silicon Biosystems operates in a competitive market with competitors including NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others.
- Headquarter Bologna, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Menarini Silicon Biosystems Spa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.53 M (USD)
in 3 rounds
-
Latest Funding Round
$15.98 M (USD), Series C
Feb 01, 2010
-
Investors
Innogest Capital
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Menarini
(Sep 12, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Silicon Biosystems
Silicon Biosystems offers a comprehensive portfolio of products and services, including CELLSEARCH, CellMag, and DEPArray.
Test for detecting circulating tumor cells in blood for cancer monitoring.
System for immunomagnetic enrichment of circulating tumor cells.
Technology for single cell isolation and molecular analysis.
People of Silicon Biosystems
Unlock access to complete
Funding Insights of Silicon Biosystems
Silicon Biosystems has successfully raised a total of $25.53M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $15.98 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Silicon Biosystems
Silicon Biosystems has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Innogest Capital and Menarini Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed and early stage companies in Italy
|
Locked | Locked | Locked | |
|
Menarini Group is engaged in pharmaceutical and healthcare solutions.
|
Locked | Locked | Locked |
Investor details for Silicon Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Silicon Biosystems
Silicon Biosystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CellSearch.
Investment portfolio details for Silicon Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Circulating tumor cells are detected via specialized blood tests.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Silicon Biosystems
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Silicon Biosystems
Detailed financials for Silicon Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Silicon Biosystems Comparisons
Peer comparison for Silicon Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Silicon Biosystems
Silicon Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Digital PCR solutions for research are developed and analyzed.
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Developer of a technology to isolate and recover single cells for molecular analysis
|
Detailed competitors of Silicon Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Silicon Biosystems
Complete news archive for Silicon Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Silicon Biosystems
Silicon Biosystems was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Silicon Biosystems is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Silicon Biosystems is a funded company, having raised a total of $25.53M across 3 funding rounds to date.
Silicon Biosystems was founded in 1999 in Bologna, Italy, within the biotechnology sector. Lab-on-a-chip solutions are created for cell-biology applications. DNA amplification from single cells is enabled by the Ampli1 whole genome kit. Cells are isolated using DEPArray technology based on dielectrophoresis. An automated DEPArray system is utilized for identifying and recovering rare cells, while Cell Browser software supports image-guided selection of specific cell populations.
Silicon Biosystems's top competitors include NanoCellect Biomedical, GenMark Diagnostics and ThinkCyte.
Silicon Biosystems offers CELLSEARCH, CellMag, and DEPArray.
Silicon Biosystems has made 1 acquisition, including CellSearch.
Silicon Biosystems has 2 investors. Key investors include Innogest Capital, and Menarini Group.